As we have continued to expand the FreeStyle franchise of diabetes care systems — from testing strips to the first generation FreeStyle Libre continuous glucose monitor (CGM) to the FreeStyle Libre 2 integrated system and our latest next-gen FreeStyle Libre 3, approved for use in Europe — we are also working to expand offerings from leading insulin delivery and digital health companies to create smarter, easier-to-use systems that are making the 24/7 requirements of the best diabetes care as seamless as possible.
Our FreeStyle Libre 2 system lasts 14 days per sensor and is the only integrated CGM that measures glucose every minute — five times more often than other CGMs1,2 — all while meeting the highest level of accuracy standards.3 It can alert you within a minute if you’re too high or too low without having to scan.4 And, compared to other CGMs, it does all that for 70% less,5 making it both accessible and affordable.
But it can do more. So here's a taste of what’s in store:
MDI: For people managing their diabetes with multiple daily injections (MDI), FreeStyle Libre 2 is designed to be compatible with Bigfoot’s Unity insulin delivery system as well as Novo Nordisk and Sanofi insulin pens.
"Both Abbott and Bigfoot understand the real-world use of diabetes devices. A no-calibration glucose sensor is the final piece of the puzzle needed to enable consumer-friendly and accessible integrated insulin delivery systems," said Jeffrey Brewer, Bigfoot Biomedical president and chief executive officer.
"With partners like Abbott, our connected pens will give healthcare professionals a better understanding of a patient’s individual diabetes management and can help people with diabetes feel more confident in their treatment," said Anders Dyhr Toft, corporate vice president, Commercial Innovation, Novo Nordisk.
Added Jared Watkin, senior vice president, Diabetes Care, Abbott: "Diabetes can be overwhelming. It's an information-rich condition with various streams of data from multiple devices. Building a digital ecosystem around FreeStyle Libre technology simplifies the user experience by consolidating how people get their data — both through offering Abbott’s digital health tools and by working with other diabetes and technology leaders."
AUTOMATED INSULIN DELIVERY: We are working with Tandem and Insulet to integrate FreeStyle Libre technology to offer more options for people living with type 1 or type 2 diabetes and using insulin pumps.
"We’re excited to integrate our insulin delivery systems with Abbott's glucose-sensing technology, and we look forward to expanding options for our customers so that they can combine devices that best suit their personal needs," said John Sheridan, president and CEO of Tandem Diabetes Care.
"As interoperability becomes increasingly important, our approach to automated insulin delivery will change the future of blood glucose management by offering consumers greater choice in algorithms, sensors and overall experience. This collaboration furthers our shared vision to help our consumers put diabetes in the background, so they have more freedom to enjoy life," said Shacey Petrovic, President and Chief Executive Officer, Insulet.
COACHING: Omada’s digital health coaching platform uses data from FreeStyle Libre 14 day system for a tailored, personalized experience for people with diabetes.
FreeStyle Libre14 day’s one-second scans for real-time glucose readings every minute, current glucose trends and historical trends and patterns. Combined with Omada Health's leading platform, users have actionable information that supports them as they better manage their diabetes, including seamless data tracking and virtual coaches to help them along the way.
And with our FreeStyle LibreLink and Libre LinkUp apps, we're helping more people easily manage their diabetes remotely.
What's next? More. That’s always in store. We’ll keep you posted.
The FreeStyle LibreLink app is compatible with NFC enabled phones on Apple’s iPhone 7 and later, running iOS 11 and later.
1 Data on file. Abbott Diabetes Care.
2 Dexcom G6 CGM User Guide.
3 Based on FDA iCGM special controls.
4 Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device.
5 Based on a comparison of list prices of the FreeStyle Libre 14 day system versus competitors' CGM systems. FreeStyle Libre 2 system will be list priced the same rate as FreeStyle Libre 14 day system. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.